AXCELIS TECHNOLOGIES INC. overview

Axcelis Announces Timing and Availability of First Quarter 2024 Results and Conference Call PR Newswire BEVERLY, Mass., April 11, 2024 BEVERLY, Mass. , April 11, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) will release financial results for the first quarter of 2024 on Wednesday, May 1, 2024, at 4:00 p.m. Eastern Time (ET). The Company will host a call to discuss the results for the first quarter 2024 on Thursday, May 2, 2024 , at 8:30 a.m. ET . The call will be available to...

Axcelis Announces Shipment of 'Purion EXE SiC Power Series' Implanter and Successful 'Purion H200 SiC Power Series' Eval Closure at Leading Power Device Manufacturers in Japan PR Newswire BEVERLY, Mass., April 2, 2024 BEVERLY, Mass. , April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a...

Axcelis Announces Multiple Shipments of 150mm 'Purion M SiC Power Series' Implanters to Leading Power Device Manufacturers in China PR Newswire BEVERLY, Mass., March 20, 2024 BEVERLY, Mass. , March 20, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today multiple shipments of the Company's Purion M™ SiC medium current implanter to several leading power device chipmakers located...

Axcelis Announces Participation in SEMICON China 2024 PR Newswire BEVERLY, Mass., March 14, 2024 BEVERLY, Mass. , March 14, 2024 /PRNewswire/ -- Axcelis Technologies , Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will sponsor the Power and Compound Semiconductor Forum at SEMICON China 2024. The event is being held March 20-22, 2024 , at the Shanghai New International Expo Center. During the Forum, Axcelis...

Thinking about buying stock in Marpai, Axcelis Technologies, Amylyx Pharmaceuticals, Biomx, or X4 Pharmaceuticals? PR Newswire NEW YORK, March 11, 2024 NEW YORK , March 11, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRAI, ACLS, AMLX, PHGE, and XFOR. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. MRAI:...

AXCELIS STRENGTHENS ITS BOARD WITH THE ELECTION OF TWO DIRECTORS PR Newswire BEVERLY, Mass., Feb. 28, 2024 BEVERLY, Mass. , Feb. 28, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that Gregory Graves and Necip Sayiner have been elected to the Company's Board of Directors. "We are pleased to welcome Gregory Graves and Dr. Necip Sayiner to the Axcelis board," said President...

Axcelis Announces Financial Results for Fourth Quarter and Full Year 2023 PR Newswire BEVERLY, Mass., Feb. 7, 2024 Record Revenue for 2023, Achieving Year-Over-Year Growth of 23% BEVERLY, Mass. , Feb. 7, 2024 /PRNewswire/ -- Axcelis Technologies , Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2023 . Highlights include: Record full year revenue, operating profit and EPS, enabling the Company to surpass its $1.1 billion revenue model....

Axcelis Announces Participation in Upcoming Investor Conferences PR Newswire BEVERLY, Mass., Jan. 30, 2024 BEVERLY, Mass. , Jan. 30, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: Wolfe Research Inaugural Semiconductor Conference, taking place at The Jay Autograph Collection, San Francisco ,...